GoodRx Holdings Inc. [NASDAQ: GDRX] closed the trading session at $4.06 on 11/09/22. The day’s price range saw the stock hit a low of $3.8201, while the highest price level was $4.632. The company report on November 8, 2022 that GoodRx Reports Third Quarter 2022 Results.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Third quarter financial results exceed previously announced guidance.
GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading consumer-focused digital platform, has released its financial results for the third quarter of 2022.
The stocks have a year to date performance of -87.58 percent and weekly performance of -18.80 percent. The stock has been moved at -47.55 percent over the last six months. The stock has performed -15.59 percent around the most recent 30 days and changed -46.58 percent over the most recent 3-months.
If compared to the average trading volume of 3.21M shares, GDRX reached to a volume of 6029725 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about GoodRx Holdings Inc. [GDRX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GDRX shares is $9.27 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GDRX stock is a recommendation set at 2.70. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
JP Morgan have made an estimate for GoodRx Holdings Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on November 04, 2022. While these analysts kept the previous recommendation, KeyBanc Capital Markets raised their target price to Sector Weight. The new note on the price target was released on September 16, 2022, representing the official price target for GoodRx Holdings Inc. stock. Previously, the target price had yet another raise to $6.50, while Truist analysts kept a Hold rating on GDRX stock.
The Average True Range (ATR) for GoodRx Holdings Inc. is set at 0.40, with the Price to Sales ratio for GDRX stock in the period of the last 12 months amounting to 2.03. The Price to Book ratio for the last quarter was 2.05, with the Price to Cash per share for the same quarter was set at 1.82. Price to Free Cash Flow for GDRX in the course of the last twelve months was 9.33 with Quick ratio for the last quarter at 11.20.
GDRX stock trade performance evaluation
GoodRx Holdings Inc. [GDRX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -18.80. With this latest performance, GDRX shares dropped by -15.59% in over the last four-week period, additionally sinking by -47.55% over the last 6 months – not to mention a drop of -90.38% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GDRX stock in for the last two-week period is set at 32.56, with the RSI for the last a single of trading hit 27.57, and the three-weeks RSI is set at 35.49 for GoodRx Holdings Inc. [GDRX]. The present Moving Average for the last 50 days of trading for this stock 5.30, while it was recorded at 4.89 for the last single week of trading, and 11.11 for the last 200 days.
GoodRx Holdings Inc. [GDRX]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and GoodRx Holdings Inc. [GDRX] shares currently have an operating margin of +3.72 and a Gross Margin at +89.10. GoodRx Holdings Inc.’s Net Margin is presently recorded at -3.39.
Return on Equity for this stock declined to -3.27, with Return on Assets sitting at -1.61.
GoodRx Holdings Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 11.20 and a Current Ratio set at 11.20.
Earnings per share (EPS) analysis for GoodRx Holdings Inc. [GDRX] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GDRX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for GoodRx Holdings Inc. go to 13.60%.
GoodRx Holdings Inc. [GDRX]: Insider Ownership positions
There are presently around $633 million, or 84.80% of GDRX stock, in the hands of institutional investors. The top three institutional holders of GDRX stocks are: FRANCISCO PARTNERS MANAGEMENT, LP with ownership of 84,700,550, which is approximately 0% of the company’s market cap and around 1.50% of the total institutional ownership; MORGAN STANLEY, holding 18,857,492 shares of the stock with an approximate value of $76.56 million in GDRX stocks shares; and VANGUARD GROUP INC, currently with $28.79 million in GDRX stock with ownership of nearly 19.922% of the company’s market capitalization.
Positions in GoodRx Holdings Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 108 institutional holders increased their position in GoodRx Holdings Inc. [NASDAQ:GDRX] by around 19,981,711 shares. Additionally, 77 investors decreased positions by around 10,839,276 shares, while 41 investors held positions by with 125,050,180 shares. The mentioned changes placed institutional holdings at 155,871,167 shares, according to the latest SEC report filing. GDRX stock had 52 new institutional investments in for a total of 4,151,546 shares, while 41 institutional investors sold positions of 9,010,340 shares during the same period.